MEDIVIR Sustainability Profile
Medivir AB, commonly referred to as Medivir, is a Swedish biopharmaceutical company headquartered in Stockholm, Sweden. Founded in 1988, Medivir has established itself in the biotechnology industry, focusing primarily on the development of innovative antiviral therapies. The company is renowned for its expertise in drug discovery and development, particularly in the fields of oncology and infectious diseases. Medivir's core products include a range of proprietary antiviral treatments, with a notable emphasis on therapies targeting hepatitis C and other viral infections. The company has achieved significant milestones, including partnerships with leading pharmaceutical firms, which have bolstered its market position. With a commitment to advancing healthcare solutions, Medivir continues to make strides in the biopharmaceutical landscape, contributing to improved patient outcomes globally.
DitchCarbon Score
How does MEDIVIR's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MEDIVIR's score of 26 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MEDIVIR's reported carbon emissions
MEDIVIR, headquartered in Sweden (SE), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that MEDIVIR may not yet have established a formal framework for addressing its carbon footprint or engaging in climate action initiatives. As the industry increasingly prioritises sustainability, it will be essential for MEDIVIR to consider developing and communicating its climate commitments to align with global standards and expectations.
How Carbon Intensive is MEDIVIR's Industry?
How Carbon Intensive is MEDIVIR's Location?
MEDIVIR's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MEDIVIR has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
